Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • INTU vs MRNA✓SelectedUSD · MRNAINTU vs MRNA performance historyLatest closeAs of+1.13%11/16
Stock and ETF performance explorer

INTU vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-44.3%
MRNA return
-8.0%
Excess return
-36.3%
Maximum drawdown
-68.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+1.1%-3.6%+4.8%+1.3%
7D+2.2%-20.0%+22.1%+3.4%
30D+6.3%-1.3%+7.5%+6.0%
3M+0.4%+240.0%-239.5%-11.8%
6M-11.3%+339.0%-350.2%-25.4%
YTD-47.1%+630.0%-677.1%-59.5%
1Y-47.1%+769.1%-816.2%-60.7%
3Y-36.3%+181.2%-217.5%-47.8%
5Y-44.3%-8.1%-36.2%-48.1%
All-44.3%-8.0%-36.3%-48.1%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling